Agoracom Blog Home

Archive for the ‘Featured’ Category

Monarques Gold intersects 17.1 g/t Au over 5.9 metres (19.4 feet) on Gold Bug (Croinor Gold) $MQR.ca

Posted by AGORACOM-JC at 2:00 PM on Tuesday, April 4th, 2017

Drilling confirms that the shear corridor is mineralized over a width of 15 metres, to a vertical depth of at least 115 metres

MONTREAL, April 4, 2017MONARQUES GOLD CORPORATION (“Monarques” or the “Corporation”) (TSX-V: MQR) (FRANKFURT: MR7) is pleased to announce the results of drilling in the Gold Bug area, which lies less than 500 metres from the Croinor Gold deposit.

The 2017 drilling program on Gold Bug was aimed at testing the gold-bearing potential of the zone discovered by the Corporation in January, when Hole CR-16-521 returned an intersection of 8.41 g/t Au over 25 metres (see press release dated January 24, 2017).

Drilling has confirmed that the shear corridor contains anomalous to economic gold grades over a width of about 15 metres, to a vertical depth of at least 115 metres. Hole CR-17-532 intersected 6.96 g/t Au over 15 metres (see plan view), including 17.1 g/t Au over 5.9 metres. That intersection, as well as those from Holes CR-17-526 and CR-17-533, confirms that the shear corridor intersected near surface in Hole CR-16-521 is about 15 metres wide. In addition, Holes CR-17-527 and CR-17-528 returned 0.27 g/t Au over 8.6 metres (from 101.1 to 109.7 metres) and 0.97 g/t Au over 6.7 metres (from 158.1 to 164.8 metres), respectively, demonstrating that the shear corridor extends to a vertical depth of approximately 115 metres. The shear corridor remains open along strike and at depth.

“The results for Gold Bug show increasingly attractive economic gold potential due to the width and depth of the gold-bearing structure discovered in January,” said Jean-Marc Lacoste, President and Chief Executive Officer of Monarques. “We believe that this area could eventually add to the resource for the Croinor Gold project. A key advantage at Gold Bug is that the structure lies close to surface, and could therefore be mined more easily, at a lower cost. This area will remain a high-priority drill target, with further testing of the structure along strike and at depth.”

The following table shows the results for the 2017 drilling program on Gold Bug:

Hole

From (m)

To (m)

Length (m)

Au (g/t)

CR-17-526

   Including

35.8

41.0

51.2

44.2

15.4

3.2

0.69

2.49

CR-17-527

   Including

101.1

101.1

109.7

104.8

8.6

3.7

0.27

0.45

CR-17-528

   Including

158.1

159.5

164.8

161.9

6.7

2.4

0.97

1.73

CR-17-529

166.3

168.3

2.0

0.10

CR-17-530

106.7

107.7

1.0

0.37

CR-17-531

   Including

43.9

49.3

49.8

49.8

5.9

0.5

0.29

2.22

CR-17-532

   Including

21.0

21.0

36.0

26.9

15.0

5.9

6.96

17.07

CR-17-533

   Including

43.3

46.3

61.9

49.5

18.6

3.2

0.63

2.04

 

The widths shown are core lengths; true width cannot be estimated. High grades were cut to 70 g/t, which is the cutoff grade used to calculate the resource estimate for the Croinor Gold deposit.

The technical and scientific content of this press release has been reviewed and approved by Donald Trudel, P.Geo., B.Sc., the Corporation’s Qualified Person under National Instrument 43-101.

Sampling normally consisted of sawing the core into two equal halves along its main axis and shipping one of the halves to the ALS Minerals laboratory in Val-d’Or for assaying. The samples are crushed, pulverized and assayed by fire assay with atomic absorption finish. Results exceeding 3.0 g/t are re-assayed using the gravity method, and samples containing gold grains are assayed using the metallic sieve method. Monarques has established a full QA/QC protocol, including the insertion of standards, blanks and duplicates.

ABOUT MONARQUES GOLD CORPORATION

Monarques Gold is a growing junior gold company focused on becoming the leading explorer and developer of gold properties in the Val-d’Or/Abitibi gold camp in Quebec, Canada. The Corporation currently has approximately 200 km² of gold exploration properties (see map) along the Cadillac Break, as well as its main asset, the Croinor Gold mine, which has great potential to become a producing mine. Monarques Gold is well financed and has close to $9 million in credits from Quebec’s Ministry of Energy and Natural Resources.

(Watch our latest Corporate Video)

Forward-Looking Statements

The forward-looking statements in this press release involve known and unknown risks, uncertainties and other factors that may cause Monarques’ actual results, performance and achievements to be materially different from the results, performance or achievements expressed or implied therein. Neither TSX Venture Exchange nor its Regulation Services. Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE Monarques Gold Corporation

 

To view the original version on PR Newswire, visit: http://www.newswire.ca/en/releases/archive/April2017/04/c5950.html

Jean-Marc Lacoste, President and CEO, 1-888-994-4465 x 201, jm.lacoste@monarquesgold.com, www.monarquesgold.comCopyright CNW Group 2017

Tetra Bio-Pharma and IntelGenx Announce the Signing of a Definitive Agreement for the Development and Commercialization of a Dronabinol XL Tablet $TBP.ca

Posted by AGORACOM-JC at 8:45 AM on Monday, April 3rd, 2017

Tbp large

  • Signed definitive agreement for the development and commercialization of a drug product containing the cannabinoid Dronabinol
  • for the management of anorexia and cancer chemotherapy-related pain
  • U.S. cancer pain market is expected to reach $5 billion in 2018

OTTAWA, ONTARIO–(April 3, 2017) - Tetra Bio-Pharma Inc. (“Tetra“) (CSE:TBP)(OTC PINK:GRPOF) and IntelGenx Corp. (“IntelGenx”) (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the signing of a definitive agreement for the development and commercialization of a drug product containing the cannabinoid Dronabinol (the “Product”) for the management of anorexia and cancer chemotherapy-related pain. The U.S. cancer pain market is expected to reach $5 billion in 2018. This definitive agreement follows the binding term sheet between the two companies that was announced on February 9, 2017.

Pursuant to the definitive agreement, Tetra has exclusive rights to sell the Product in North America, with a right of first negotiation for territories outside of the United States and Canada. Tetra will make an upfront payment to IntelGenx, in addition to set future milestone and royalty payments, based on the completion of an efficacy study, approvals from the U.S. Food and Drug Association (“FDA”) and Health Canada, and the commercial launch of the Product. IntelGenx will be responsible for the research and development of the Product, including clinical studies, and will develop the product as an oral mucoadhesive tablet based on its proprietary AdVersa® controlled-release technology. Tetra will be responsible for funding the product development, and will own and control all regulatory approvals, including the related applications, and any other marketing authorizations. Tetra will also be responsible for all aspects of commercializing the Product.

“We are pleased to announce the closing of the definitive agreement with IntelGenx and look forward to working very hard with them to bring this much-needed product to patients suffering from cancer pain,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “The execution of this agreement is just the beginning for Tetra as we look forward to aggressively concluding future agreements as we build a leading bio-pharmaceutical organization focused on developing medicinal cannabis as pharmaceutical drugs.”

“The U.S. cancer pain market is expected to reach $5 billion in 2018, and the quick growing medical cannabis industry is poised to capture a signature portion of that opportunity,” said Dr. Horst G. Zerbe, President and CEO of IntelGenx. “We are pleased to be working with Tetra to bring this much-needed cannabinoid product to North American patients suffering from anorexia and cancer chemotherapy-related pain.”

Background Information: 

There are many clinical problems associated with the use of currently available form of Dronabinol in patients with anorexia and cancer chemotherapy-related pain. It has been demonstrated that psychoactive drugs exert their euphoria, and other psychoactive effects, when the blood levels of the drug rapidly increase. The pharmacokinetic profile of tetrahydrocannabinol (“THC”) and its metabolite increases the abuse potential of cannabinoids like Dronabinol. The significant advantage of an oral mucoadhesive tablet based on IntelGenx’ proprietary AdVersa® controlled-release technology is that it can be adjusted to achieve a predetermined drug release pattern by increasing the residence time, promoting intimate contact with the mucosal tissue and increasing the bioadhesive properties of the dosage form. It is believed that, by deploying this technology in the controlled-release of THC, a longer time release of the drug will be achieved and, thereby, a rapid increase in the blood will be avoided. There will also potentially be improved bioavailability and reduced gastro-intestinal side effects, making a sustained-release THC product a promising alternative in the battle for the reduction of opioids in patients with chronic pain.

About IntelGenx:

IntelGenx is a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. Established in 2003, the Montreal-based company is listed on the TSX-V and OTC-QX.

IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx state-of-the art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. More information is available about the company at: www.intelgenx.com.

About Tetra Bio Pharma: 

Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP) (OTC PINK:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
edward@tetrabiopharma.com
(343) 689-0714
www.tetrabiopharma.com

HPQ Silicon Resources Provides Update on Spin out of Beauce Gold Project, Listing and Distribution to Shareholders $HPQ.ca

Posted by AGORACOM-JC at 9:33 AM on Friday, March 31st, 2017

Hpq large

  • Patrick Levasseur, President and COO of HPQ Silicon stated, “The spin out of our gold assets into Beauce Gold Fields is nearing completion and will prove to be worth the wait for our shareholders and everyone who will benefit from it. The recent signing of our MOU with Golden Hope Mines regarding the Bellechasse-Timmins Gold Deposit allows us to now focus our efforts to spin out Beauce Gold Fields. The TSX-V has received documentation therefore we are now waiting for a positive response of this documentation. We are eager for Beauce Gold Fields to be an independently trading entity that unlocks the true value of our gold assets.”

MONTREAL, QUEBEC–(March 31, 2017) - HPQ-Silicon Resources Inc. (TSX VENTURE:HPQ) (FRANKFURT:UGE) (OTC PINK:URAGF) wishes to provide to its shareholders an update regarding the spin out of its Beauce Gold Project into Beauce Gold Fields Inc. (“BGF”) and its application for listing on the Canadian Securities Exchange (“CSE”).

Patrick Levasseur, President and COO of HPQ Silicon stated, “The spin out of our gold assets into Beauce Gold Fields is nearing completion and will prove to be worth the wait for our shareholders and everyone who will benefit from it. The recent signing of our MOU with Golden Hope Mines regarding the Bellechasse-Timmins Gold Deposit allows us to now focus our efforts to spin out Beauce Gold Fields. The TSX-V has received documentation therefore we are now waiting for a positive response of this documentation. We are eager for Beauce Gold Fields to be an independently trading entity that unlocks the true value of our gold assets.”

PROPOSED DISTRIBUTION OF BEAUCE GOLD FIELDS SHARES TO HPQ SILICON SHAREHOLDERS

Once HPQ receives notice of the acceptance of its documents by the TSX-V, we will complete the final documentation for our CSE listing. At that point, we will announce the proposed distribution of BGFI shares, the record date on which HPQ shareholders will qualify to receive such shares and the proposed listing date of BGFI. BGFI would issue 25.1 million shares of its share capital to HPQ in consideration of the sale of the Beauce-Placer-Fancamp claims, the Beauce Placer claims and the exploration and extraction rights for precious and base metals on the Roncevaux property. The per share value currently being considered for BGFI is $0.10. The proposed distribution of the shares will be done under a three year escrow. 10% of the shares should be releaseded upon listing, and 15% should then be released every 6 months afterwards, effectively shareholders should receive 40% of their BGFI shares during the first year.

ADDITIONAL SPIN OUT MATTERS

The following actions have been completed in relation to the spin out:

  1. HPQ has entered into an agreement to grant to BGF the Gold, Precious metals and base metals exploration and extraction rights on the Roncevaux property in exchange for a 5% NSR on such production and the issuance of 100,000 shares.
  2. HPQ has entered into an agreement selling the Beauce-Placer-Fancamp claims and the Beauce Placer claims, the Beauce Gold Project, and the Real Estate lots relating thereto, in exchange for 25 million shares
  3. The Corporation has received and filed on SEDAR both the updated National Instrument 43-101-compliant report on the Beauce Placer Project, as well as, a NI 43-101-compliant report on the Roncevaux property.
  4. The Board of Directors of Beauce Gold Fields Inc has been nominated and is composed of:
  • Dr.Vivian Stuart-Williams, M. Sc. Geo. SACNASPS
  • Mr. Michael Flanagan, P. Geo (Québec)
  • Mr. Marc-André Drapeau, ing.
  • Mr. Bernard Tourillon
  • Mr. Patrick Levasseur
  1. The Officers of BGFI have nominated and will be composed of:
  • Mr. Bernard Tourillon, Chairman and CEO
  • Mr. Patrick Levasseur, President and COO
  • Mr. François Rivard, Chief Financial Officer
  1. The Corporation has filed with the TSX-Venture Exchange the necessary documents regarding the various claims sales, the real estate lots and exploration and extraction rights Agreements..

CAPITAL RAISE

Concurrently with the listing process on CSE Exchange, BGF is in the process of raising in excess of $400,000 to qualify for listing. This will enable the Corporation to meet its working capital obligations as well as most of its first year exploration needs.

About HPQ Silicon

HPQ Silicon Resources Inc is a TSX-V listed junior exploration company planning to become a vertically integrated and diversified High Value Silicon Metal (99.9+% Si), and Solar Grade Silicon Metal (99.999+% Si) producer.

Our business model is focused on developing a one step High Purity and Solar Grade Silicon Metal manufacturing process (patent pending) and becoming a vertically – integrated Solar Grade Silicon producer that can generate high yield returns and significant free cash flow within a relatively short time line.

About Beauce Gold Fields

Beauce Gold Fields (BGF) is a wholly own subsidiary of HPQ Silicon. HPQ is in the process of “Spinning Out” Beauce Gold Fields into a new publicly trading junior gold company. The Beauce Gold property will become the property of merit of BGF.

The Beauce Gold project is a unique, historically prolific gold field located in the municipality of Saint-Simon-les-Mines in the Beauce region of Southern Quebec. Comprising of a block of claims 100 per cent owned by HPQ, the project area hosts a six-kilometre-long unconsolidated gold-bearing sedimentary unit (a lower saprolite and an upper brown diamictite) holding the largest historical placer gold deposit in eastern North America. The gold in saprolite indicates a close proximity to a bedrock source of gold, providing significant potential for further exploration discoveries.

Property highlights

  • Certificate of authorizations (CA) allowing the start of first phase mining activities on the Rang Chaussegros sector of the Beauce gold project;
  • Polygonally calculated gold exploration target for the entire historical placer channel ranging between 61,000 ounces (2.2 million cubic metres at 0.87 gram of gold per cubic metre) and 366,000 ounces (2.2 million cubic metres at 5.22 grams of gold per cubic metre);
  • Significant potential for further exploration discoveries; geology suggest a proximate bedrock source of gold;
  • 176 acres of real estate 100 per cent owned by HPQ;
  • The property once held four historical gold mining operations;
  • The property produced the largest gold nuggets in Canadian mining history (St-Onge nugget, 43 ounces; McDonald nugget, 45 ounces; Kilgour nugget, 51 ounces).

Disclaimers:

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Shares outstanding: 168 387 616

Patrick Levasseur
President and COO
(514) 262-9239
www.HPQSilicon.com

AGORACOM Welcomes Monarques Gold (MQR: TSX-V) With NI 43-101 High-Grade Gold Reserves and Resources $MQR.ca

Posted by AGORACOM-JC at 8:54 AM on Thursday, March 30th, 2017

Monarquesgold hub large

 

Why Monarques Gold?

  • NI 43-101 high-grade gold reserves and resources
  • Excellent discovery potential along strike and at depth
  • Ongoing 10,000 drilling program (results are pending)
  • Acquisition of the 750 ton-per-day Beacon mill

Croinor Gold Property

Flagship project at the prefeasibility stage

  • 100% interest in the Croinor Gold property, a gold mine project that is currently at the prefeasibility stage
  • Property consists of one mining lease and two non-contiguous blocks of claims for a total of 335 claims over a 151 km² area. A 1.5% NSR is applicable on the mining lease and only 44 claims.
  • Drilling program will test a diorite-hosted gold-bearing zone that returned grades of up to 38.7 g/t Au over 3.8 metres in historical drilling (see release)

 WATCH OUR CORPORATE VIDEO

Check Out Croinor Gold
Prefeasability Study

Simkar Gold Property

NI 43-101 Gold Resource 20 km from Val-d’Or

  • 100% interest in the Simkar Gold property
  • located 20 kilometres east of Val-d’Or, in the heart of the Abitibi Greenstone Belt.
  • Comprised of two mining concessions and 15 claims covering an area of 5 km², and is subject to a 1.5% NSR.
  • NI 43-101 (click here)

The Simkar Gold property is the result of a merger of the Simkar and Texsol properties. The transaction was announced by way of press release on June 26, 2014.

Regcourt Gold Property – Val d’Or

  • 100% interest in the Regcourt Gold property
  • Property is located at the eastern end of the Val-d’Or gold mining camp, some 30 km east of Val-d’Or, and is easily accessible via Route 117.
  • Consists of 94 claims covering an area of 38 km2 near the centre of the western border of Vauquelin Township
  • Property is subject to a 1.5% and 2.5 % NSR.

 

12 Month Stock Chart

Last changed at 27-Mar-2017 04:41PM by AGORACOM

 


 

HPQ Silicon Resources and Golden Hope Mines Sign MOU on Bellechasse-Timmins Gold Property to Move Forward $HPQ.ca

Posted by AGORACOM-JC at 8:15 AM on Friday, March 24th, 2017

Hpq large

  • Announced that Golden Hope Mines (“GNH”) (TSX VENTURE:GNH) and HPQ have signed a non-binding Memorandum of Understanding (MOU)
  • New Agreement in relation to the commercial mining of the of the Bellechasse-Timmins (“B-T”) gold deposit located in St-Magloire in the Beauce region of Quebec

MONTREAL, QUEBEC–(March 24, 2017) - HPQ Silicon Resources Inc (“HPQ”) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGF) is pleased to announce that Golden Hope Mines (“GNH”) (TSX VENTURE:GNH) and HPQ have signed a non-binding Memorandum of Understanding (MOU) for a New Agreement in relation to the commercial mining of the of the Bellechasse-Timmins (“B-T”) gold deposit located in St-Magloire in the Beauce region of Quebec.

ADVANCING THE BELLECHASSE-TIMMINS GOLD PROPERTY

HPQ strongly believes that, similar to its Beauce Gold project, the B-T property can potentially be advanced to the feasibility level for a small-scale surface gold mining operation. The B-T property and the Beauce Gold property have many points in common, key among them is the fact that the deposits are located in the Magog Group geological formation and are both “nuggety” type deposits.

Patrick Levasseur, President and COO of HPQ Silicon stated “I look forward to working with the Golden Hope Mines team to advance the B-T deposit into the first operating gold mine in southern Quebec in many years. I sincerely thank the Board of Golden Hope and especially its President, Frank Candido, for his leadership in bringing us together to find common ground to move forward with this fantastic project for the benefit of all shareholders.”

The MOU sets the framework to end the legal dispute (see HPQ press release of September 18 2015 and GNH press releases of September 4 and 21 and November 12 and 23 2015) and establish a New Agreement that replaces the Definitive Option and Joint Venture Agreement (DOJV) for the advancement of the B-T Deposit into a producing mine. (see press releases February 24 and April 4 of 2014)

A Preliminary Economic Assessment and a Feasibility Study has not been completed and there is no certainty the proposed operation will be economically viable or mineable.

Mr. Mike Flanagan, PGeo. is the qualified person as defined by National Instrument 43-101 who has prepared and approved of the technical information in this news release. 

NEW AGREEMENT EXPECTED TO BE COMPLETED APRIL 15 – KEY POINTS BELOW

  1. Upon conclusion of the New Agreement, the DOJV shall be terminated, HPQ shall withdraw the UBR Legal Action and each party shall release the other from any claim, right or obligation relating to the DOJV.
  2. The New Agreement shall provide HPQ the option to earn a 30% undivided interest in the B-T Deposit by completing, at its cost, a list of actions specified and detailed in the New Agreement
  3. The New Agreement shall provide HPQ with a further option to earn an additional 20% undivided interest in the Deposit (total 50%), following the completion of all Actions, by securing the required financing to fully fund the commercial production of the Deposit in accordance with the Economic Assessment referred to above.
  4. HPQ will subscribe to a private placement financing of GNH.
  5. An assignment of HPQ’s rights and obligations under the New Agreement to HPQ’s wholly-owned subsidiary Beauce Goldfields (BGF) may take place upon completion of certain conditions stipulated in the New Agreement.
  6. In the event that HPQ does assign its rights and obligations under the New Agreement to BGF, GNH shall receive $50,000 in shares of BGF, subject to required approvals.

The New Agreement is expected to be completed and executed by the parties by April 15, 2017.

About HPQ Silicon

HPQ Silicon Resources Inc is a TSX-V listed junior exploration company planning to become a vertically integrated and diversified High Value Silicon Metal (99.9+% Si), and Solar Grade Silicon Metal (99.999+% Si) producer.

Our business model is focused on developing a one step High Purity and Solar Grade Silicon Metal manufacturing process (patent pending) and becoming a vertically – integrated Solar Grade Silicon producer that can generate high yield returns and significant free cash flow within a relatively short time line.

About Beauce Gold Fields

Beauce Gold Fields (BGF) is a wholly own subsidiary of HPQ Silicon. HPQ is in the process of “Spinning Out” Beauce Gold Fields into a new publicly trading junior gold company. The Beauce Gold property will become the property of merit of BGF.

The Beauce Gold project is a unique, historically prolific gold field located in the municipality of Saint-Simon-les-Mines in the Beauce region of Southern Quebec. Comprising of a block of claims 100 per cent owned by HPQ, the project area hosts a six-kilometre-long unconsolidated gold-bearing sedimentary unit (a lower saprolite and an upper brown diamictite) holding the largest historical placer gold deposit in eastern North America. The gold in saprolite indicates a close proximity to a bedrock source of gold, providing significant potential for further exploration discoveries.

Property highlights

  • Certificate of authorizations (CA) allowing the start of first phase mining activities on the Rang Chaussegros sector of the Beauce gold project;
  • Polygonally calculated gold exploration target for the entire historical placer channel ranging between 61,000 ounces (2.2 million cubic metres at 0.87 gram of gold per cubic metre) and 366,000 ounces (2.2 million cubic metres at 5.22 grams of gold per cubic metre);
  • Significant potential for further exploration discoveries; geology suggest a proximate bedrock source of gold;
  • 176 acres of real estate 100 per cent owned by HPQ;
  • The property once held four historical gold mining operations;
  • The property produced the largest gold nuggets in Canadian mining history (St-Onge nugget, 43 ounces; McDonald nugget, 45 ounces; Kilgour nugget, 51 ounces).

Disclaimers:

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Shares outstanding: 164 704 382

Patrick Levasseur
President and COO
(514) 262-9239
www.HPQSilicon.com

TARTISAN RESOURCES ADDED TO CSE COMPOSITE INDEX $TTC.ca

Posted by AGORACOM-JC at 6:59 PM on Friday, March 17th, 2017

Tartisan logo copy

The quarterly rebalancing of the CSE Composite Index will result in the following changes, effective after the close on Friday, March 17, 2017.

Additions

TTC – Tartisan Resources Corp.

For more information about the CSE Composite Index, including the full list of securities and the index methodology, visit the CSE website.

Contact Information

Index Management

Robert Cook, Senior Vice-President Market Development

Robert.Cook@thecse.com          (416) 367-7349

Media Relations

Richard Carleton, CEO

Richard.Carleton@thecse.com  (416) 367-7360

Read bulletin: http://thecse.com/en/about/publications/bulletins/2017-0307-index-cse-composite-index-quarterly-rebalancing

Explor Intersects Multiple Copper Zones Grades Up to 2.36% Cu Over 11.5 Meters on the Chester Copper Property $EXS.ca

Posted by AGORACOM-JC at 1:46 PM on Thursday, March 16th, 2017

Exs logo

  • Multiple Copper Zones Grades Up to 2.36% Cu Over 11.5 Meters
  • Chief Executive Officer of Explor Resources Inc. commented: “We are extremely pleased and encouraged by these preliminary drill results. The presence of multiple copper mineralized zones in each of the holes drilled is very significant in terms of exploration. The increase in strike length of the known mineralization from 500 to 750 meters confirms the potential to significantly increase the resources on the property. The property continues to be open on strike to the west and Northwest.”

ROUYN-NORANDA, CANADA – (March 16, 2017) - Explor Resources Inc. (“Explor” or the “Corporation“) (TSX VENTURE:EXS)(OTCQB:EXSFF)(FRANKFURT:E1H1)(BERLIN:E1H1) is pleased to announce further results from the 12 Diamond Drill Holes completed on the Chester Copper Property. The Chester Copper property is located in the Northumberland County, 70 km southwest of Bathurst, New Brunswick and 50 km west-northwest of Miramichi, New Brunswick, within the Bathurst Mining Camp. This area has an extensive history in base metal production from VMS deposits.

There has been very little exploration work in this area of the Bathurst Mining Camp (BMC) since the initial exploration more than 60 years ago. Of significance also is the fact that three (3) age date studies of the rock in the area since 2005 have indicated an age of 469+/- 0.3 ma. All of the main largest VMS deposits in the BMC (including BMS #12 and #6, the Caribou Deposit (currently being developed by Travalli) and the past producing Heath Steele Mines, are associated with this age date for the footwall felsic rocks. That new data in 2007 places Explor’s Chester deposit is in the same time frame as the Brunswick Mining No. 12 and No. 6 deposits located in the BMC.

New Brunswick is the home of the No 12 massive sulphide deposit (The Brunswick Deposit) which was in continuous production from 1964 to its closure in March of 2013 (to Feb 2013, 135,903,168 tonnes milled at 3.44 % Pb, 8.74 % Zn, 0.37 % Cu and 102 g/t Ag). The Brunswick deposits (No 6 and No 12) are situated in the Nepisiguit Falls Group of rocks in the Lower Tetagouche group of the BMC. There are 46 known VMS deposits in the BMC.

The property is located in the southern-most part of the Bathurst Mining Camp and consist of 174 Mineral Claim Units within a total of five (5) Mineral Claims (1571, 2428, 6003, 6005 and 7045) comprising approximately 3,828 hectares as shown on the attached map.

Chris Dupont, President and Chief Executive Officer of Explor Resources Inc. commented: “We are extremely pleased and encouraged by these preliminary drill results. The presence of multiple copper mineralized zones in each of the holes drilled is very significant in terms of exploration. The increase in strike length of the known mineralization from 500 to 750 meters confirms the potential to significantly increase the resources on the property. The property continues to be open on strike to the west and Northwest.”

A total of 4 diamond drill holes were drilled on claim 1571. The first three diamond drill holes that were drilled were fan holes from the same location. This successfully tested the extension of the copper stringer zone for a distance of 250 meters west of previous drilling. The fourth drill hole was located approximately 100 meters west (and 38 meters south) of the first three drill holes, confirming the continuity of the mineralization to the west and Northwest and adding 250 meters of strike length to the known deposit. It intersected the target horizon and favorable geology from 49 meters to 172 meters.

Further to the west the copper deposit goes down dip and onto claim 6003. At about 1,100 meters west of the first drill hole, drill hole 6003-16-012 was drilled at a vertical dip. It eventually went to a depth of 600 meters and intersected previously unknown mineralization near surface (18 meters) and also extending the deep main Chester Stringer zone an additional 650 meters westward than any previous reliable drilling (i.e. casing in place and core in government storage). It also confirms the existence of the alteration zone and the host stratigraphic horizon to a depth not previously known or expected. The chloritized favorable horizon extends from a depth of 472.5 meters to 561 meters with low grade copper mineralization documented from 519 meters to 543 meters.

In the north part of claim 6003, an untested soil geochemical anomaly was tested. Copper mineralization was discovered as pyrrhotite and chalcopyrite veinlets in felsic volcanic associated with the soil anomaly. Copper mineralization was also discovered in this area in 2014 and a soil survey on claim 7045 to the west have unexplained copper and lead anomalies which may be associated with previously mentioned soil anomaly and this horizon.

To the south on Claim 6005, two drill holes were put down to test a soil anomaly apparently associated with a historical drill hole, dating to about the 1956 to 1958 era, with a reported value of more than 2% copper. No indication of any mineralization was discovered in the two drill holes.

Results are shown below for Hole # 1571-16-004:

Summary of Results From Drill Hole 1571-16-004
Zones From
(m)
To
(m)
Length
(m)
Au
(ppb)
Ag
(ppm)
Cu
(%)
Zn
(ppm)
Pb
(ppm)
1 89.20 90.00 0.80 10 1 0.013 1189 370
Contains bedded pyrite (very narrow zone) (Anomalous in zinc and lead)
Main mineralized zone below 90 m, very chloritic
2 120.90 123.00 2.10 46 2.8 0.832 346 73
3 131.90 143.40 11.50 138 4.8 2.357 1205 107
includes 131.90 137.45 5.45 134 4.8 2.267 1428 101
and 137.35 143.40 6.05 142 4.8 2.439 100 113
or 135.80 143.40 7.60 173 6.1 3.058 1408 158
includes 139.70 143.40 3.70 211 7.1 3.885 1492 134
4 161.90 164.20 2.30 21 1.0 0.436 160 36
5 178.70 181.40 2.70 51 1.6 0.781 235 60
includes 178.70 179.30 0.60 114 4.4 3.160 457 167
6 201.50 202.40 0.90 28 2 1.150 168 20
7 232.90 234.60 1.70 146 1.4 0.64 109 29
8 267.00 268.00 1.00 2.5 1.4 0.028 12500 1572
9 270.00 271.00 1.00 2.5 0.1 0.035 2501 216

A total of 9 zones of Copper mineralization were intersected in the above referenced Hole # 1571-16-004Zinc mineralization of 1.25% was intersected over 1.0 meters.

Results are shown below for Hole # 1571-16-012:

Summary of Results From Drill Hole 1571-16-012
Zones From
(m)
To
(m)
Length
(m)
Au
(ppb)
Ag
(ppm)
Cu
(%)
Zn
(ppm)
Pb
(ppm)
1 12.80 13.10 0.30 58 1.4 0.120 64 44
2 16.10 18.30 2.20 11.4 1.35 0.098 32 22
3 18.30 32.20 13.90 3.1 0.62 0.028 118 20
4 519.00 528.90 9.90 7.8 0.9 0.375 77.5 24.6
includes 521.10 521.60 0.53 40 5.6 3.380 186 31
and 525.00 526.40 1.35 14 1.5 0.898 121 29
5 531.00 536.50 5.50 26.6 0.6 0.235 54.0 24.3
includes 534.70 535.10 0.40 186 5.4 2.950 235 57
N.B. “From” and “to” are vertical depth from surface

A total of 5 zones of copper mineralization were intersected in the above referenced Hole # 1571-16-012.

The Chester Property is known to contain both a copper deposit and a VMS deposit. The copper deposit has an Open Pit resource with Measured & Indicated resource of 1,400,000 tonnes grading 1.38% Cu, 0.06% Zn & 3.5 g/t Ag and an inferred resource of 2,089,000 tonnes grading 1.26% Cu (assayed for Cu only).

Chris Dupont, P.Eng is the qualified person responsible for the information contained in this release.

Explor Resources Inc. is a publicly listed company trading on the TSX Venture (EXS), on the OTCQB (EXSFF) and on the Frankfurt and Berlin Stock Exchanges (E1H1).

This Press Release was prepared by Explor. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the Policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.

About Explor Resources Inc.

Explor Resources Inc. is a Canadian-based natural resources company with mineral holdings in Ontario, Québec, Saskatchewan and New Brunswick. Explor is currently focused on exploration in the Abitibi Greenstone Belt. The belt is found in both provinces of Ontario and Québec with approximately 33% in Ontario and 67% in Québec. The Belt has produced in excess of 180,000,000 ounces of gold and 450,000,000 tonnes of cu-zn ore over the last 100 years. The Corporation was continued under the laws of Alberta in 1986 and has had its main office in Québec since 2006.

Explor Resources Flagship project is the Timmins Porcupine West (TPW) Project located in the Porcupine mining camp, in the Province of Ontario. Teck Resources Ltd. is currently conducting an exploration program as part of an earn-in on the TPW property. The TPW mineral resource (Press Release dated August 27, 2013) includes the following:

Open Pit Mineral Resources at a 0.30 g/t Au cut-off grade are as follows: 
Indicated: 213,000 oz (4,283,000 tonnes at 1.55 g/t Au) 
Inferred: 77,000 oz (1,140,000 tonnes at 2.09 g/t Au) 
Underground Mineral Resources at a 1.70 g/t Au cut-off grade are as follows: 
Indicated: 396,000 oz (4,420,000 tonnes at 2.79 g/t Au) 
Inferred: 393,000 oz (5,185,000 tonnes at 2.36 g/t Au) 

This document may contain forward-looking statements relating to Explor’s operations or to the environment in which it operates. Such statements are based on operations, estimates, forecasts and projections. They are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and may be beyond Explor’s control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements, including those set forth in other public filling. In addition, such statements relate to the date on which they are made. Consequently, undue reliance should not be placed on such forward-looking statements. Explor disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.

A map is available at the following address: http://media3.marketwire.com/docs/1089056A_Fig1.pdf.  

Christian Dupont
President
888-997-4630 or 819-797-4630
819-797-1870
www.explorresources.com
info@explorresources.com

Tetra Bio-Pharma Enters into Binding Term Sheet for Two Products with Panag Pharma $TBP.ca

Posted by AGORACOM-JC at 10:25 AM on Tuesday, March 14th, 2017

Tbp large

  • Entered into a binding term sheet with Panag Pharma Inc. for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation
  • Combined total market potential of both products in the USA in 2014 is estimated over US$5.5 billion

OTTAWA, ONTARIO–(March 14, 2017) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), announced today it has entered into a binding term sheet with Panag Pharma Inc. for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation. Combined total market potential of both products in the USA in 2014 is estimated over US$5.5 billion.

Per the binding term sheet, Tetra will have exclusive access to sell the ocular and topical drug products in North America with right of first negotiation for outside U.S. and Canadian territories. In addition, Tetra will have a right of first negotiation for future products.

Tetra will be working in close collaboration with Panag’s team of experts to ensure a rapid and successful development. Tetra shall be responsible for 100% of the research and development of the Licensed Products. Tetra will own and control all regulatory approvals in the Territory, including the application and any other marketing authorizations within the Territory and shall be responsible for all aspects of commercializing the drug products.

Panag has developed potential new cannabinoid-based therapies for ocular and topical anti-inflammatory and pain markets. The total ocular anti-inflammatory market was estimated at over $3 billion in the USA in 2014 and includes conditions such as post-op inflammation, allergic conjunctivitis and inflammatory dry eye. Panag also developed a cannabinoid topical drug product for the treatment of local neuropathic and non-neuropathic pain. In 2014, the over the counter sales of topical analgesics were estimated at over $2.5 billion according to IMS.

“This announcement further demonstrates Tetra’s commitment to shareholders to add future products to our product portfolio in an effort of building a leading bio- pharmaceutical organization,” said Andre Rancourt, CEO of Tetra Bio-Pharma. “This will further allow Tetra to generate revenues in 2017 through its partnership with Panag. Tetra is going to work closely with Panag to exploit its innovative technology that indirectly acts on the CB2 receptor with the goal of launching several products in the retail market. This is in-line with Tetra’s goal of commercializing products pending legalization.”

According to Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma, “We are going to prioritize the development of the ocular therapy as this is a promising innovative product and the potential financial reward will be significant. Tetra had already positioned itself to become a leader in topical pain relief with its PPTGR technology. With the Panag partnership, Tetra is going to modify its development plans to accelerate bringing an innovative cannabinoid topical drug product to the market. The Panag team is going to strengthen Tetra’s overall scientific knowledge and expertise base making it one of the leading biotechnology companies developing cannabinoid-based therapies.”

About Panag Pharma:

Panag Pharma Inc. is a Canadian based bio-tech company focused on the development of novel cannabinoid based formulations for the treatment of pain and inflammation. Panag believes that pain relief should be safenon-addictive and above all; effective. The Panag Pharma team of PhD scientists and medical doctors are among the world’s leading researchers and clinicians in the area of pain treatment and management. They bring a combined experience of over 100 years in research and clinical care of people dealing with chronic pain and inflammatory conditions. Panag’s current pipeline of pain relief products include formulations for the topical application to the skin, the eye and other mucous membranes. Recently approved by Health Canada and currently undergoing clinical trials, Panag Pharma’s Topical AOTC provides a new approach to the treatment of chronic pain and inflammation.

About Tetra Bio-Pharma:

Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Dr. Guy Chamberland
Chief Science Officer
(514) 220-9225

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer
(343) 689-0714
www.tetrabiopharma.com

Namaste Announces MOU With Vinergy $N.ca

Posted by AGORACOM-JC at 8:22 AM on Tuesday, March 14th, 2017

Nlogo

  • Entered a memorandum of understanding with Vinergy Resources Ltd., to jointly market Vinergy’s proprietary Cannabidiol (CBD) extract formulations through referral traffic generated on Namaste’s sales channels and websites
  • CEO of Namaste, comments: “We are very pleased to work with Vinergy to further expand our product line. This relationship represents continued monetization of Namaste’s database and we view broadening our strategic alliances to the benefit of our customers and shareholders”.

VANCOUVER, BRITISH COLUMBIA–(March 14, 2017) -Namaste Technologies Inc. (“Namaste” or the “Company“) (CSE:N)(CSE:N.CN)(OTCQB:NXTTF)(FRANKFURT:M5BQ) is pleased to announce that it has entered a memorandum of understanding (“MOU“) with Vinergy Resources Ltd. (“Vinergy“), to jointly market Vinergy’s proprietary Cannabidiol (CBD) extract formulations through referral traffic generated on Namaste’s sales channels and websites.

In the first phase of the collaboration, through channels in California, Colorado and potentially other legal States, Namaste will market Vinergy’s proprietary formulations to consumers in its database of 300,000 customers.

Management Commentary 

Mr. Sean Dollinger, President and CEO of Namaste, comments: “We are very pleased to work with Vinergy to further expand our product line. This relationship represents continued monetization of Namaste’s database and we view broadening our strategic alliances to the benefit of our customers and shareholders”.

About Namaste Technologies Inc. 

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 ecommerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.vaporseller.com

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
+1 (786) 389 9771
info@namastevapes.com
www.namastetechnologies.com

INTERVIEW: Grizzly Discusses Greenwood Project Currently Under Option to Kinross $GZD.ca $K.ca

Posted by AGORACOM-JC at 3:52 PM on Monday, March 13th, 2017